Showing 171-180 of 3897 results for "".
SC: not just a dead layer
https://practicaldermatology.com/topics/general-topics/sc-not-just-a-dead-layer/19528/Take a deep look inside the stratum corneum (SC) and understand its role in overall skin health. Learn what metabolic processes are important to SC health and, in turn, what processes are affected by a suboptimal SC.Journal Club: Colloidal Oat for Prevention and Treatment
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-colloidal-oat-for-prevention-and-treatment/32407/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Editorial Board member Lawrence Eichenfield, MD, FAAD, discuss a study demonstrating the benefits of oat for infant skincare, especially for the treatment and mitigation of atopic dermatitis.The Big Idea: Jeanine Downie, MD on Hiring Decisions
https://practicaldermatology.com/topics/practice-management/the-big-idea-jeanine-downie-md-on-hiring-decisions/19277/Dr. Downie discusses the important considerations in hiring, including how to spot the best candidates and ensure a top-notch patient experience. Featured in "What's the Big Idea"The Big Idea: Jeanine Downie, MD on Practice Planning
https://practicaldermatology.com/topics/practice-management/the-big-idea-jeanine-downie-md-on-practice-planning/19279/Dr. Downie discusses the benefits of a defined benefits pension plan and why she incorporated it into her practice plan from the start. Featured in "What's The Big Idea."Journal Club: Does the Epithelial Barrier Hypothesis Explain the Increase In Allergy, Autoimmunity, and Other Chronic Conditions?
https://practicaldermatology.com/columns/research-reports/journal-club-does-the-epithelial-barrier-hypothesis-explain-the-increase-in-allergy-autoimmunity-and-other-chronic-conditions/24040/DermWireTV: Pfizer, AbbVie JAKs for AD; Spray-on-Skin; Lubriderm Scholarships
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-pfizer-abbvie-jaks-for-ad-spray-on-skin-lubriderm-scholarships/20043/For the treatment of refractory moderate-to-severe atopic dermatitis, FDA has approved Pfizer’s Cibinqo (abrocitinib) for adults and AbbVie’s Rinvoq (upadacitinib) for patients 12 and older. Researchers at the Houston Methodist Research Institute have paired their patented RNA technologies with AvitIf you had to pick one—skydiving, bungee jumping, or scuba diving—which would you do?
https://practicaldermatology.com/topics/general-topics/if-you-had-to-pick-one-skydiving-bungee-jumping-or-scuba-diving-which-would-you-do/19831/Bruce Strober, MD says his choice is the one that offers him a whole new experience that he's never seen before. Watch now to learn his choice.The Big Idea: Jeanine Downie, MD on Purchasing Her Own Space
https://practicaldermatology.com/topics/practice-management/the-big-idea-jeanine-downie-md-on-purchasing-her-own-space/19278/Dr. Downie explains why she wanted her own space and describes the major and minor benefits of ownership, including cost savings. Featured in "What's The Big Idea"Journal Club: AD's Impact on Mental Health
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-ads-impact-mental-health/28628/Practical Dermatology Editorial Board member Peter Lio, MD, chats with dermatologist Robert Sidbury, MD, MPH, about the Cureus article, "Investigation of the Impact of Atopic Dermatitis (AD) on Stress, Depression, Anxiety, and Suicidal Ideation: A Systematic Review and Meta-Analysis."Journal Club: Updates in Topical Treatments for AD
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-updates-topical-treatments-ad/29744/Editorial Board member and dermatologist Dr. Peter Lio talks with Dr. Ted Lain, a dermatologist at Sanova Dermatology, about the latest research and developments in topical treatments for AD. The discussion covers a range of therapies highlighted in an article from the Dermatologic Clinics article "